ArticleBlood2009

Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide.

Judith E Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.